FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkï¾® (NCCN) as its 28th…
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) published updated recommendations on use of hepatitis A…
On Nov. 2, 2018, AcelRx pharmaceutical’s DSUVIA was approved by U.S. Food and Drug Administration (FDA). DSUVIA is…
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
On Oct. 3, 2018, the Nobel Foundation announced that Frances H. Arnold had won a share of the…
On Oct. 1, 2018, James P. Allison, a native of Alice, Texas, son of a country doctor, and…
On Sept. 27, 2018, Researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
On Sept. 27, 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a collaboration with The Jenner Institute…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 13, 2018, the Genome 10K (G10K) announced the launch of the international Vertebrate Genomes Project (VGP),…
On Sept. 11, 2018, the National Science Foundation (NSF) awarded a three year $1 million grant to scientists…
On Sept. 11, 2018, the NSF launched the 2026 Idea Machine: A mechanism to set the stage for…